{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:31:49Z","timestamp":1786422709327,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014786","name":"Northern Border University","doi-asserted-by":"publisher","award":["NBU-CRP-2026-2042"],"award-info":[{"award-number":["NBU-CRP-2026-2042"]}],"id":[{"id":"10.13039\/501100014786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cca.2026.121115","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:09:34Z","timestamp":1779466174000},"page":"121115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Urinary melatonin: A non-invasive breast cancer biomarker"],"prefix":"10.1016","volume":"591","author":[{"given":"Abida","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayaa M.","family":"Alhuthali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani A.","family":"Alrehaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed S.","family":"Alharthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121115_bb0005","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cca.2026.121115_bb0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2026.121115_bb0015","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s12094-024-03541-1","article-title":"Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology","volume":"26","author":"Colomer","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cca.2026.121115_bb0020","article-title":"The utility of serum tumor markers CEA and CA 15\u20133 for breast cancer prognosis and their association with clinicopathological parameters","volume":"28","author":"Uygur","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.cca.2026.121115_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.cca.2026.121115_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biom15071006","article-title":"Circadian biomarkers in humans: methodological insights into the detection of melatonin and cortisol","volume":"15","author":"Skubic","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2026.121115_bb0035","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.tem.2020.08.001","article-title":"Melatonin: a potential therapeutic option for breast cancer","volume":"31","author":"Kong","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121115_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4068\/cmj.2025.61.2.63","article-title":"Melatonin and breast cancer: a review article","volume":"61","author":"Motehaver","year":"2025","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.cca.2026.121115_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041051","article-title":"Urinary biomarkers and point-of-care urinalysis devices for early diagnosis and management of disease: a review","volume":"11","author":"Sequeira-Antunes","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121115_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050633","article-title":"Noninvasive urinary biomarkers for obesity-related metabolic diseases: diagnostic applications and future directions","volume":"15","author":"Zhan","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2026.121115_bb0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/cclm-2020-0455","article-title":"Mass spectrometric quantification of urinary 6-sulfatoxymelatonin: age-dependent excretion and biological variation","volume":"59","author":"van Faassen","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121115_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101614","article-title":"Reference intervals for 6-sulfatoxymelatonin in urine: a meta-analysis","volume":"63","author":"Braam","year":"2022","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.cca.2026.121115_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-0716-2593-4_4","article-title":"Measuring urinary 6-sulphatoxymelatonin in humans","volume":"2550","author":"St Hilaire","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cca.2026.121115_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1414463","article-title":"Dual sources of melatonin and evidence for different primary functions","volume":"15","author":"Reiter","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.121115_bb0075","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1039\/D5FO00971E","article-title":"Daily walnut consumption increases 6-sulfatoxymelatonin urinary levels and can improve sleep quality: a randomized crossover trial","volume":"16","author":"Zer\u00f3n-Rugerio","year":"2025","journal-title":"Food Funct."},{"key":"10.1016\/j.cca.2026.121115_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12657","article-title":"Measuring melatonin by immunoassay","volume":"69","author":"Kennaway","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12664","article-title":"Journal of pineal research guideline for authors: measuring melatonin in humans","volume":"69","author":"Lockley","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12773","article-title":"Measuring morning melatonin levels with plasma melatonin ELISA kits is a poor choice on two levels","volume":"72","author":"Kennaway","year":"2022","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17061916","article-title":"Melatonin-measurement methods and the factors modifying the results. A systematic review of the literature","volume":"17","author":"Rzepka-Migut","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cca.2026.121115_bb0100","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1038\/s41598-022-12084-w","article-title":"A genome-wide association study for melatonin secretion","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121115_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.buildenv.2023.111025","article-title":"The effect of spectrally and intensity-modified daylighting on urinary melatonin levels in office workers under real-life conditions","volume":"247","author":"Stebelov\u00e1","year":"2024","journal-title":"Build. Environ."},{"key":"10.1016\/j.cca.2026.121115_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/sleepadvances\/zpaf077","article-title":"Serum 25-hydroxyvitamin D concentration is associated with device-estimated sleep metrics in healthy young and early middle-aged adults","volume":"6","author":"D\u2019Agata","year":"2025","journal-title":"Sleep Adv."},{"key":"10.1016\/j.cca.2026.121115_bb0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000363426","article-title":"Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature","volume":"9","author":"Basler","year":"2014","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.cca.2026.121115_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/1055-9965.EPI-13-1028","article-title":"Urinary levels of melatonin and risk of postmenopausal breast cancer: Women's Health Initiative observational cohort","volume":"23","author":"Sturgeon","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/aje\/kwu261","article-title":"Urinary melatonin concentration and the risk of breast cancer in nurses\u2019 health study II","volume":"181","author":"Brown","year":"2015","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cca.2026.121115_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1158\/1055-9965.EPI-16-0630","article-title":"Urinary melatonin in relation to postmenopausal breast cancer risk according to melatonin 1 receptor status","volume":"26","author":"Devore","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.sleep.2018.11.022","article-title":"Disruption of sleep, sleep-wake activity rhythm, and nocturnal melatonin production in breast cancer patients undergoing adjuvant chemotherapy: prospective cohort study","volume":"55","author":"Li","year":"2019","journal-title":"Sleep Med."},{"key":"10.1016\/j.cca.2026.121115_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-025-00863-3","article-title":"Night shift work and breast cancer: from etiopathology to precision risk analysis","volume":"12","author":"Vivarelli","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.cca.2026.121115_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/172460080602100408","article-title":"Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer","volume":"21","author":"Barba","year":"2006","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.cca.2026.121115_bb0150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1055-9965.EPI-18-1018","article-title":"Shift work, chronotype, and melatonin rhythm in nurses","volume":"28","author":"Razavi","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207736","article-title":"Impact of dim light at night on urinary 6-sulphatoxymelatonin concentrations and sleep in healthy humans","volume":"21","author":"Stebelova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121115_bb0160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.sleep.2020.09.018","article-title":"Association between night-shift work and level of melatonin: systematic review and meta-analysis","volume":"75","author":"Wei","year":"2020","journal-title":"Sleep Med."},{"key":"10.1016\/j.cca.2026.121115_bb0165","article-title":"Urinary excretion of 6-sulfatoxymelatonin, the main metabolite of melatonin, and mortality in stable outpatient renal transplant recipients","volume":"9","author":"Veen","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121115_bb0170","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1007\/s11356-023-31502-8","article-title":"Association between nocturnal light exposure and melatonin in humans: a meta-analysis","volume":"31","author":"Lu","year":"2024","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.cca.2026.121115_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70017","article-title":"Identification of predictors of shift work adaptation and its association with immune, hormonal and metabolite biomarkers","volume":"76","author":"Harding","year":"2024","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40268-024-00482-6","article-title":"Melatonin bioavailability after oral administration of a new delayed-release form in healthy male volunteers","volume":"24","author":"Ait Abdellah","year":"2024","journal-title":"Drugs R D"},{"key":"10.1016\/j.cca.2026.121115_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchromb.2014.11.016","article-title":"Determination of urinary cortisol, cortisone and 6-sulfatoxymelatonin using dilute and shoot ultra-high pressure liquid chromatography-tandem mass spectrometry","volume":"978\u2013979","author":"Sniecinska-Cooper","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2026.121115_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2018.07.035","article-title":"Simultaneous quantification of urinary 6-sulfatoxymelatonin and 8-hydroxy-2\u2032-deoxyguanosine using liquid chromatography-tandem mass spectrometry","volume":"1095","author":"He","year":"2018","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2026.121115_bb0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0004563220980496","article-title":"A comparison of two LC-MS\/MS methods and one radioimmunoassay for the analysis of salivary melatonin","volume":"58","author":"Karel","year":"2021","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121115_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3343\/alm.2021.41.1.108","article-title":"A sensitive and specific liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of salivary melatonin and cortisol: development and comparison with immunoassays","volume":"41","author":"Shin","year":"2021","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.cca.2026.121115_bb0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1248\/cpb.c21-00982","article-title":"Development and validation of an LC-MS\/MS-based method for quantifying urinary endogenous 6-hydroxymelatonin","volume":"70","author":"Ohki","year":"2022","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.cca.2026.121115_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123664","article-title":"UPLC-MS\/MS simultaneous quantification of urinary circadian rhythm hormones and related metabolites: application to air traffic controllers","volume":"1222","author":"Xu","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cca.2026.121115_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.128627","article-title":"A method for simultaneous analysis of urinary melatonin, cortisol, and their metabolites using liquid chromatography tandem mass spectrometry and relevance of biomonitoring of these hormones in circadian rhythm","volume":"297","author":"Martinez-Moral","year":"2026","journal-title":"Talanta"},{"key":"10.1016\/j.cca.2026.121115_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122938","article-title":"Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS\/MS","volume":"1181","author":"Magliocco","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cca.2026.121115_bb0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/ph19030439","article-title":"Analytical methods for melatonin quantification: advances, challenges, and clinical applications","volume":"19","author":"Butiulca","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cca.2026.121115_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01256753","article-title":"Urinary melatonin levels in human breast cancer patients","volume":"52","author":"Bartsch","year":"1981","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cca.2026.121115_bb0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-079X.1990.tb00686.x","article-title":"6-sulphatoxymelatonin production in breast cancer patients","volume":"8","author":"Skene","year":"1990","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-079X.1997.tb00335.x","article-title":"Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size","volume":"23","author":"Bartsch","year":"1997","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djh077","article-title":"Melatonin and breast cancer: a prospective study","volume":"96","author":"Travis","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cca.2026.121115_bb0250","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/jnci\/dji190","article-title":"Urinary melatonin levels and breast cancer risk","volume":"97","author":"Schernhammer","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cca.2026.121115_bb0255","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/jnci\/djn171","article-title":"Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women","volume":"100","author":"Schernhammer","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cca.2026.121115_bb0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1055-9965.EPI-08-0637","article-title":"Urinary melatonin levels and postmenopausal breast cancer risk in the nurses\u2019 health study cohort","volume":"18","author":"Schernhammer","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0265","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1158\/1055-9965.EPI-09-1229","article-title":"Urinary 6-sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort","volume":"19","author":"Schernhammer","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0270","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/aje\/kwt302","article-title":"First-morning urinary melatonin and breast cancer risk in the Guernsey study","volume":"179","author":"Wang","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cca.2026.121115_bb0275","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/1055-9965.EPI-20-0822","article-title":"Urinary melatonin in relation to breast cancer risk: nested case-control analysis in the DOM study and meta-analysis of prospective studies","volume":"30","author":"Wong","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0280","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1038\/s41598-017-05752-9","article-title":"Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121115_bb0285","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1590\/1806-9282.65.5.699","article-title":"Repercussions of melatonin on the risk of breast cancer: a systematic review and meta-analysis","volume":"65","author":"Veiga","year":"2019","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"key":"10.1016\/j.cca.2026.121115_bb0290","article-title":"Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study","volume":"365","author":"Richmond","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.121115_bb0295","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa166","article-title":"Sleep duration and breast cancer incidence: results from the million women study and meta-analysis of published prospective studies","volume":"44","author":"Wong","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.cca.2026.121115_bb0300","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1515\/med-2022-0470","article-title":"The relationship between night shift work and breast cancer incidence: a systematic review and meta-analysis of observational studies","volume":"17","author":"Hong","year":"2022","journal-title":"Open Med. (Wars.)"},{"key":"10.1016\/j.cca.2026.121115_bb0305","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s11325-021-02523-9","article-title":"Night-shift work, breast cancer incidence, and all-cause mortality: an updated meta-analysis of prospective cohort studies","volume":"26","author":"Wei","year":"2022","journal-title":"Sleep Breath."},{"key":"10.1016\/j.cca.2026.121115_bb0310","doi-asserted-by":"crossref","first-page":"17746","DOI":"10.1038\/s41598-024-68856-z","article-title":"Sleep traits and breast cancer risk: a two-sample Mendelian randomization study","volume":"14","author":"Feng","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121115_bb0315","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1186\/s12889-024-19518-2","article-title":"Night shift work and female breast cancer: a two-stage dose-response meta-analysis for the correct risk definition","volume":"24","author":"Moon","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cca.2026.121115_bb0320","first-page":"94","article-title":"Night shift work and breast cancer risk - 2023 update of epidemiologic evidence","volume":"5","author":"Hansen","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.cca.2026.121115_bb0325","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/1055-9965.936.13.6","article-title":"Epidemiology of urinary melatonin in women and its relation to other hormones and night work","volume":"13","author":"Schernhammer","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0330","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1158\/1055-9965.EPI-07-0530","article-title":"Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women","volume":"16","author":"Nagata","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0335","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1055-9965.EPI-12-0005","article-title":"Rotating night shift work and mammographic density","volume":"21","author":"Peplonska","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0340","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ijc.27653","article-title":"Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore","volume":"132","author":"Wu","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2026.121115_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020419","article-title":"Circadian disruption and breast cancer risk: evidence from a case-control study in China","volume":"15","author":"Song","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121115_bb0350","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/annonc\/mdt283","article-title":"A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer","volume":"24","author":"Wang","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cca.2026.121115_bb0355","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-079X.2005.00285.x","article-title":"Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels","volume":"40","author":"Schernhammer","year":"2006","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0360","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/aas.12157","article-title":"Sleep disturbances and changes in urinary 6-sulphatoxymelatonin levels in patients with breast cancer undergoing lumpectomy","volume":"57","author":"Hansen","year":"2013","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.cca.2026.121115_bb0365","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-014-2962-2","article-title":"Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial","volume":"145","author":"Hansen","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cca.2026.121115_bb0370","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10549-014-2944-4","article-title":"A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes","volume":"145","author":"Chen","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cca.2026.121115_bb0375","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5664\/jcsm.5490","article-title":"Effect of melatonin on sleep in the perioperative period after breast cancer surgery: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Madsen","year":"2016","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.cca.2026.121115_bb0380","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1093\/oncolo\/oyad250","article-title":"Melatonin supplementation for cancer-related fatigue in patients with early stage breast cancer receiving radiotherapy: a double-blind placebo-controlled trial","volume":"29","author":"Mukhopadhyay","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.cca.2026.121115_bb0385","article-title":"Melatonin aids in treating mood and sleep problems resulting from hormonal therapy in breast cancer patients: a randomized, double-blinded, placebo-controlled trial","volume":"23","author":"Vaziri","year":"2024","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.cca.2026.121115_bb0390","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/NNR.0000000000000578","article-title":"Longitudinal analysis of sleep disturbance in breast cancer survivors","volume":"71","author":"Yang","year":"2022","journal-title":"Nurs. Res."},{"key":"10.1016\/j.cca.2026.121115_bb0395","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10549-022-06792-0","article-title":"Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review","volume":"198","author":"D'Cunha","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cca.2026.121115_bb0400","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.sleh.2023.04.004","article-title":"Global prevalence of sleep disturbances among breast cancer survivors: a systematic review with meta-analysis","volume":"9","author":"Cheng","year":"2023","journal-title":"sleep Health"},{"key":"10.1016\/j.cca.2026.121115_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1340920","article-title":"Return to work, work productivity loss and activity impairment in Chinese breast cancer survivors 12-month post-surgery: a longitudinal study","volume":"12","author":"Ng","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.cca.2026.121115_bb0410","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ijerph21081057","article-title":"Returning to work after breast cancer: a one-year mixed-methods study","volume":"21","author":"Magnavita","year":"2024","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cca.2026.121115_bb0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/abr.abr_352_22","article-title":"Exploring the efficacy of melatonin in alleviating menopausal symptoms in breast cancer survivors: a randomized, double-blind, placebo-controlled study","volume":"14","author":"Sattari","year":"2025","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.cca.2026.121115_bb0420","article-title":"Comparison of the diagnostic performances of circulating tumor cells and the serum tumor markers CEA, CA125, and CA15-3 for breast cancer: a retrospective case-control study","volume":"4","author":"Luan","year":"2021","journal-title":"J. Bio-X Res."},{"key":"10.1016\/j.cca.2026.121115_bb0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.33393\/jcb.2022.2446","article-title":"Diagnostic impact of CEA and CA 15-3 on chemotherapy monitoring of breast cancer patients","volume":"11","author":"Hasan","year":"2022","journal-title":"J. Circ. Biomark."},{"key":"10.1016\/j.cca.2026.121115_bb0430","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4048\/jbc.2023.26.e17","article-title":"Prognostic impact of elevation of cancer antigen 15-3 (CA15-3) in patients with early breast cancer with normal serum CA15-3 level","volume":"26","author":"Ryu","year":"2023","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.cca.2026.121115_bb0435","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00432-024-05917-w","article-title":"Circadian rhythms and breast cancer: from molecular level to therapeutic advancements","volume":"150","author":"Li","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121115_bb0440","doi-asserted-by":"crossref","first-page":"267","DOI":"10.25259\/IJMR_1291_2024","article-title":"Circulating tumour DNA as a promising biomarker for breast cancer diagnosis & treatment monitoring","volume":"161","author":"Ursekar","year":"2025","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.cca.2026.121115_bb0445","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-079X.1998.tb00366.x","article-title":"Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function","volume":"24","author":"Baskett","year":"1998","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.cca.2026.121115_bb0450","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5664\/jcsm.27083","article-title":"Measuring melatonin in humans","volume":"4","author":"Benloucif","year":"2008","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.cca.2026.121115_bb0455","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/1055-9965.EPI-07-0656","article-title":"Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women","volume":"17","author":"Nagata","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0460","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/1055-9965.EPI-23-0860","article-title":"Adiposity, weight change, and urinary melatonin levels among men in the multiethnic cohort","volume":"33","author":"Chowdhury-Paulino","year":"2024","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121115_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117391","article-title":"LC-MS\/MS in clinical chemistry: did it live up to its promise?: consideration from the Dutch EQAS organisation","volume":"546","author":"Lentjes","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121115_bb0470","doi-asserted-by":"crossref","first-page":"ii161","DOI":"10.1093\/ejendo\/lvaf036","article-title":"EndoCompass project: endocrine laboratory medicine","volume":"193","author":"Heijboer","year":"2025","journal-title":"Eur. J. Endocrinol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:18:18Z","timestamp":1786421898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":94,"alternative-id":["S0009898126002974"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121115","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary melatonin: A non-invasive breast cancer biomarker","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121115"}}